ASCO calls for expansion of access to clinical trials

Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer

“Our goal was very clear from the beginning, which was to develop a user-friendly simple chat-like interface that would provide specific high-quality answers to questions that our members would bring, utilizing only our content,” said Clifford A. Hudis, CEO of the American Society of Clinical Oncology and executive vice chair of the Conquer Cancer Foundation.

October 22, 2025

Vol.51 No.38

Clinical Roundup

Tukysa improves HER2+ breast cancer, phase III trial shows

The phase III HER2CLIMB-05 trial of first-line combination therapy with the tyrosine kinase inhibitor Tukysa in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer has met its primary endpoint.

October 17, 2025

Vol.51 No.38

Clinical Roundup

Enhertu demonstrates improvement in invasive DFS in HER2+ breast cancer after neoadjuvant therapy

Positive high-level results showed Enhertu (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant and clinically meaningful improvement in invasive disease-free survival versus trastuzumab emtansine in patients with HER2-positive early breast cancer with residual invasive disease in the breast or axillary lymph nodes after neoadjuvant treatment and a high-risk of disease recurrence, according to a planned interim analysis of the DESTINY-Breast05 phase III trial.

October 17, 2025

Vol.51 No.38

Clinical Roundup

Mayo tests radiopharmaceutical theranostic for HCC in first-in-human trial

Mayo Clinic administered an investigational radioactive medicine to a patient with hepatocellular carcinoma.

October 17, 2025

Vol.51 No.38

Guest Editorial

ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology

Cancer care is evolving at an unprecedented pace. Practitioners feel the mounting pressures daily: rising cancer rates—particularly in younger patients—a growing population of older cancer survivors, rapid growth in new care and treatment options, and navigating heightened fiscal constraints and uncertainty.

October 10, 2025

Vol.51 No.37

By Clifford A. Hudis and Thomas Kurian

Cancer Policy

ASCO report shows decrease in the number of oncologists relative to aging population

A report by the American Society of Clinical Oncology points to a growing challenge in cancer care access driven by a widening gap between the number of available oncologists and increasing patient demand.

October 10, 2025

Vol.51 No.37

By Claire Marie Porter

ASCO calls for expansion of access to clinical trials

YOU MAY BE INTERESTED IN

Cliff Hudis on how AI in cancer care is “inevitable”—and ASCO is working to make it safer

Tukysa improves HER2+ breast cancer, phase III trial shows

Enhertu demonstrates improvement in invasive DFS in HER2+ breast cancer after neoadjuvant therapy

Mayo tests radiopharmaceutical theranostic for HCC in first-in-human trial

ASCO and Google Cloud set forth a vision for using AI to modernize health care and advance oncology

ASCO report shows decrease in the number of oncologists relative to aging population

Renew today!

Subscriber content

Never miss an issue!

Login